Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Multi-Center, Active Comparator, Five Treatment Study of the Effects of Nebivolol Compared to Atenolol on Cardiovascular Hemodynamics and Exercise Capacity in Patients With Mild to Moderate Hypertension

NCT00200421 is registered in ClinicalTrials.gov with Mylan Bertek Pharmaceuticals as lead sponsor.

NCT NCT00200421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00200421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Multi-Center, Active Comparator, Five Treatment Study of the Effects of Nebivolol Compared to Atenolol on Cardiovascular Hemodynamics and Exercise Capacity in Patients With Mild to Moderate Hypertension
Lead sponsor
Mylan Bertek Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2002
Completion date
August 31, 2003
Enrollment
110
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension